945
Views
0
CrossRef citations to date
0
Altmetric
Public Health & Policy

A real-world study on the changing characteristics of measles antibodies in premature infants in China

, , , , , , , & ORCID Icon show all
Article: 2338505 | Received 18 Dec 2023, Accepted 31 Mar 2024, Published online: 10 Apr 2024

References

  • Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153–8. doi:10.1016/S0140-6736(10)62352-5.
  • Patel MK, Goodson JL, Alexander JP Jr., Kretsinger K, Sodha SV, Steulet C, Gacic-Dobo M, Rota PA, McFarland J, Menning L, et al. Progress toward regional measles elimination — worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69:1700–5. doi:10.15585/mmwr.mm6945a6.
  • Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M, Herring B, Kang Y, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — united states, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:591–3. doi:10.15585/mmwr.mm6919e2.
  • Wold Health Organization, United Nations International Children’s Emergency Fun. Progress and Challenges with Achieving Universal Immunization Coverage. 2023 [accessed 2024 Apr 3]. https://www.who.int/publications/m/item/progress-and-challenges.
  • Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hatcher C, Hsu CH, Ho LL, Steulet C, et al. Progress toward measles elimination — worldwide, 2000–2022. MMWR Morb Mortal Wkly Rep. 2023;72:1262–8. doi:10.15585/mmwr.mm7246a3.
  • Ma C, Hao L, Zhang Y, Su Q, Rodewald L, An Z, Yu W, Ma J, Wen N, Wang H, et al. Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data. Bull World Health Organ. 2014;92:340–7. doi:10.2471/BLT.13.130195.
  • Tapia MD, Sow SO, Medina-Moreno S, Lim Y, Pasetti MF, Kotloff K, PASETTI MF. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. Am J Trop Med Hyg. 2005;73:26–31. doi:10.4269/ajtmh.2005.73.26.
  • Ezeanolue EH, Hunter P, Kroger A, Pellegrini C. General best practice guidelines for immunization. Best practices guidance of the advisory committee on immunization practices (ACIP). US: US Department of Health and Human Services; 2019.
  • Ma C, Rodewald L, Hao L, Su Q, Zhang Y, Wen N, Fan C, Yang H, Luo H, Wang H, et al. Progress toward measles elimination—China, January 2013-June 2019. MMWR Morbidity And Mortality Weekly Report. 2019;1:21–7. doi:10.46234/ccdcw2019.008.
  • Tasher D, Stein M, Solomon C, Shachor-Meyouhas Y, Glikman D, Mandelboim M, Kassis I, Somekh E. Children hospitalised with influenza-associated pneumonia during the 2009 pandemic displayed increased disease severity. Acta Paediatr (Oslo, Norway : 1992). 2015;104:e100–5. doi:10.1111/apa.12865.
  • Marshall H, Clarke M, Rasiah K, Richmond P, Buttery J, Reynolds G, Andrews R, Nissen M, Wood N, McIntyre P. Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatr Infect Dis J. 2015;34:339–45. doi:10.1097/INF.0000000000000577.
  • Xu Y, Ji C, Liu Y, Li M, Yao D, Wang X, Du J, Chen J. Vaccination recommendations, immunization status and safety of vaccination for premature infants in Zhejiang, China. Expert Rev Vaccines. 2020;19:973–81. doi:10.1080/14760584.2020.1831917.
  • Ma R, Xu G, Xu H, Ma Y, Dong H, Li Y, Hu F, Ni H, Bian G, Liang Y, et al. Study on maternal transmission of measles antibody in young infants. Chin J Vacc Immun. 2008;14:226–8.
  • Fu C, Shen J, Lu L, Li Y, Cao Y, Wang M, Pei S, Yang Z, Guo Q, Shaman J. Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: a longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16. Vaccine. 2017;35:3817–22. doi:10.1016/j.vaccine.2017.06.002.
  • Harel-Gadassi A, Friedlander E, Yaari M, Bar-Oz B, Eventov-Friedman S, Mankuta D, Yirmiya N. Developmental assessment of preterm infants: chronological or corrected age? Res Dev Disabil. 2018;80:35–43. doi:10.1016/j.ridd.2018.06.002.
  • Mao N, Zhu Z, Jiang X. Comparison and evaluation of enzyme-linked immunization assay kits with plague reduction neutralization test for detection of measles IgG antibody. Chin J Vacc Immun. 2009;15:215–8.
  • Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS. The basic reproduction number (R(0)) of measles: a systematic review. Lancet Infect Dis. 2017;17:420–8. doi:10.1016/S1473-3099(17)30307-9.
  • Yang W, Li J, Shaman J. Characteristics of measles epidemics in China (1951-2004) and implications for elimination: a case study of three key locations. PLoS Comput Biol. 2019;15:e1006806. doi:10.1371/journal.pcbi.1006806.
  • Leuridan E, Van Damme P. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine. 2007;25:6296–304. doi:10.1016/j.vaccine.2007.06.020.
  • Hughes SL, Bolotin S, Khan S, Li Y, Johnson C, Friedman L, Tricco AC, Hahné SJM, Heffernan JM, Dabbagh A, et al. The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness – a systematic review. Vaccine. 2020;38:460–9. doi:10.1016/j.vaccine.2019.10.090.
  • National Health Commission of the People’s Republic of China. National immunization program vaccine children’s immunization procedures and instructions. 2020 [accessed 2024 Apr 3]. http://www.nhc.gov.cn/jkj/s3581/202103/590a8c7915054aa682a8d2ae8199e222.shtml.
  • Bester JC. Measles and measles vaccination: a review. JAMA Pediatr. 2016;170:1209–15. doi:10.1001/jamapediatrics.2016.1787.
  • World Health Organization. WHO position on measles vaccines. Vaccine. 2009;27:7219–21. doi:10.1016/j.vaccine.2009.09.116.
  • Chong KC, Rui Y, Liu Y, Zhou T, Jia K, Wang MH, Mohammad KN, He H. Early waning of maternal measles antibodies in infants in Zhejiang Province, China: a comparison of two cross-sectional serosurveys. Int J Environ Res Public Health. 2019;16:4680. doi:10.3390/ijerph16234680.
  • He Q, Fan S, Xue Z, Yuan J, Wang Y, Yang Z, Zhou Z, Zhang Z. Waning of maternal antibody against measles virus in Shufu. China. 2022;18:2045854. doi:10.1080/21645515.2022.2045854.
  • Javed N, Saqib MAN, Hassan Bullo MM, Asghar RJ. Seroprevalence of transplacentally acquired measles antibodies in unvaccinated infants at nine months of age and its relation to the feeding practices. BMC Infect Dis. 2019;19:587. doi:10.1186/s12879-019-4167-0.
  • Mollema L, Smits GP, Berbers GA, Van Der Klis FR, Van Binnendijk RS, De Melker HE, HAHNÉ SJM. High risk of a large measles outbreak despite 30 years of measles vaccination in the Netherlands. Epidemiol Infect. 2014;142:1100–8. doi:10.1017/S0950268813001532.
  • Linder N, Tallen-Gozani E, German B, Duvdevani P, Ferber A, Sirota L. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine. 2004;22:1509–14. doi:10.1016/j.vaccine.2003.10.009.
  • van den Berg JP, Westerbeek EA, Smits GP, van der Klis FR, Berbers GA, van Elburg RM. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLOS ONE. 2014;9:e94714. doi:10.1371/journal.pone.0094714.
  • Lennon JL, Black FL. Maternally derived measles immunity in era of vaccine-protected mothers. J Pediatr. 1986;108:671–6. doi:10.1016/S0022-3476(86)81039-3.
  • Pabst HF, Spady DW, Marusyk RG, Carson MM, Chui LW, Joffres MR, GRIMSRUD KM. Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J. 1992;11:525–9. doi:10.1097/00006454-199207000-00004.
  • Yan R, Zhou Y, Deng X, Tang X, Zhu Y, He H. Serum anti-measles antibody levels among residents in Zhejiang Province. Prev Med. 2022;34:496–502.
  • Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, Hatchette TF, Bolotin S. Waning of measles maternal antibody in infants in measles elimination settings – a systematic literature review. Vaccine. 2018;36:1248–55. doi:10.1016/j.vaccine.2018.01.002.